Pathology of Kidney Allograft Dysfunction. B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary
|
|
- Molly Jenkins
- 5 years ago
- Views:
Transcription
1 Pathology of Kidney Allograft Dysfunction B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary
2 The gold standard for exploration of the cause of an allograft dysfunction is to perform a renal allograft biopsy (Bx)
3 Evaluation of biopsies for cause in our department At least two cores Light microscopic stainings on serial sections (H&E, PAS, trichrome, methenamine silver) Immunofluorescence on frozen sections To detect rejection: C4d, HLA-DR To detect immune deposits: IgG, IgA, IgM, C3
4 Evaluation of biopsies for cause in our department Electron microscopy optional Fixation and embedding of samples in each case Examination of glomeruli if - LM of glomeruli is abnormal - IF reveals positivity - the patient has glomerular symptoms Examination of peritubular capillary (PTC) basement membrane if chronic rejection is suspected
5 Objective To review the pathology and diff. diagnosis of - rejection - CNI toxicity - post-transplantation glomerulonephritis - polyomavirus nephropathy
6 Acute T-cell-mediated rejection (TMR) Inflammatory response against HLA class II antigens expressed on endothelial cells tubular cells interstitial dendritic cells mesangial cells
7 Acute TMR Inflammatory response against HLA class II antigens expressed on endothelial cells tubular cells interstitial dendritic cells mesangial cells Effector mechanisms CD8 + CTL-mediated cytotoxicity +++ Delayed type hypersensitivity + Antibody-dependent cytotoxicity +
8 Manifestations Interstitium Tubules Tubulointerstitial rejection + Arteries Vascular rejection + Glomeruli Transplant glomerulitis
9 Tubulointerstitial rejection Interstitial oedema, lymphocytic infiltrates, and tubulitis
10 Tubulointerstitial rejection Infiltrates: predominance of CD8+ lymphocytes IF: tubular HLA-DR expression CD8+
11 Tubulitis on EM Intratubular CTLs injure tubular epithelial cells CTL CTL Apo CTL CTL Apo CTL
12 Subsiding tubulointerstitial rejection Nodular infiltrates (Tregs, CD4 +, CD8 +, CD68 + ) around newly formed lymphatics; scanty tubulitis; oedema Ø
13 Diff. dg. of tubulointerstitial rejection Acute pyelonephritis - neutrophils in infiltrates, neutrophilic casts Polyomavirus NP - nuclear inclusion bodies Drug-induced TIN - faint tubular HLA-DR staining PTLD - predominance of B-lymphocytes
14 Diff. dg. of tubulointerstitial rejection acute pyelonephritis
15 Vascular rejection Infiltration of the intima by lymphocytes + monocytes Involves the large arteries more frequently than the interlobular arteries
16 Differential diagnosis Intimal arteritis is pathognomic for acute TMR
17 Transplant glomerulitis Lymphocytes + monocytes in capillary loops Isolated glomerulitis: in 10% of cases with acute TMR
18 Differential diagnosis Recurrent or de novo proliferative GN (rejection: no immune deposits by IF)
19 Clinical correlation of acute TMR Most common cause of a graft dysfunction in the first 3 months after Tx Sudden asymptomatic rise in the serum creatinine level Bx confirms the diagnosis
20 Outcome Tubulointerstitial rejection responds well to pulse steroids Vascular rejection can be reversed with antilymphocyte antibodies If not: fibrous obliteration of arteries graft loss
21 Acute alloantibody-mediated rejection (ABMR) Donor-specific HLA class I or II antibodies Complement-mediated cytotoxic injury to the endothelial cells
22 Acute ABMR Donor-specific HLA class I or II antibodies Complement 4d degradation product binds to PTCs This stable molecule is detected by IF Complement-mediated cytotoxic injury to the endothelial cells
23 Evaluation of C4d in PTCs Immunofluorescence on frozen sections is more sensitive than immunohistochemistry on paraffin sections
24 Diagnostic criteria: serologic demonstration of DSAs, diffuse C4d+ along PTCs; evidence of tissue injury Evidence of tissue injury 1) ATN-like, minimal inflamm. 2) Peritubular capillaritis and/or thromboses 3) Transmural arteritis and/or arterial fibrinoid necrosis Racusen et al. AJT 3:1-7, 2003
25 EM Cytotoxic injury to PTC endothelial cells manifests in lysis
26 Differential diagnosis TMA secondary to CNI toxicity Recurrent HUS CMV or parvovirus B19 infection Anti-cardiolipin sy
27 Differential diagnosis TMA secondary to CNI toxicity Recurrent HUS CMV or parvovirus B19 infection Anti-cardiolipin sy Clue None of these displays C4d positivity along the PTCs
28 Clinical correlation Infrequent (2-8%) Most common in the first few weeks after Tx; oligoanuria develops within days Therapeutic efforts may reverse the rejection process Poor prognosis
29 Chronic ABMR
30 Diagnostic triad 1) Serologic demonstration of DSAs 2) Diffuse C4d+ in PTCs
31 Diagnostic triad 1) Serologic demonstration of DSAs 2) Diffuse C4d+ in PTCs 3) Histologic evidence of action of these antibodies, leading to chronic tissue injury: interstitial fibrosis and tubular atrophy and/or transplant arteriopathy and/or transplant glomerulopathy and/or transplant capillaropathy (PTC basement membrane lamination) Solez et al. AJT 7:1-9, 2006
32 Tx arteriopathy: new-onset intimal fibrosis Absence of elastosis
33 Consequence Chronic progressive ischemic injury to the graft
34 Tx glomerulopathy: double-contoured loops
35 EM: newly formed basement membrane layer(s) along the entire capillary circumference Ivanyi et al. Modern Pathol 14:1200, 2001
36 Consequences Proteinuria Focal glomerular obsolescence
37 Diff. dg.: recurrent or de novo MPGN Clue: no immunocomplexes on IF
38 Tx capillaropathy 5 or more BM layers
39 Consequence A progressive decrease in the number of PTCs
40 Ocurrence of lesions Transplant glomerulopathy most frequent Transplant capillaropathy Transplant arteriopathy less frequent
41 The cumulative occurrence of Tx glomerulopathy and Tx capillaropathy amounts to 90% The evaluation of the entire capillary bed provides a sensitive tool with which to recognize antibody-mediated tissue injury Wavamuno et al. AJT 7:2757, 2007
42 C4d-staining in chronic ABMR C4d is an insensitive marker or ABMR: less than half of the cases are negative! Sis et al. AJT 9:2312, 2009 Einecke et al. AJT 9:2520, 2009
43 Phenotypes of chronic ABMR Serology (Luminex technology), endothelial transcripts, and histopathology reveal C4d+ and C4d- chronic ABMR Taylor et al. Human Immunol 70: 563, 2010 Sis, Halloran. Curr Opin Organ Transplant 15: 42, 2010
44 Clinical correlation of chronic ABMR The most frequent cause of graft loss after 1 year Insidious, progressive decline in the GFR, frequently accompanied by proteinuria (often in the nephrotic range) and hypertension
45 Calcineurin inhibitor toxicity Cyclosporin and tacrolimus can cause acute or chronic nephrotoxicity; the lesions are identical Acute Toxic tubulopathy Vascular toxicity -Acute arteriolopathy -TMA Chronic Hyaline arteriolopathy Liptak P, Ivanyi B. Nature Clin Pract Nephrol 2:398, 2006
46 Toxic tubulopathy. Isometric vacuolization in the straight proximal tubules; interstitial edema is minimal or absent
47 The features of this tubulopathy cannot be distinguished from those of radiocontrast nephrotoxicity or osmotic nephrosis, Differential diagnosis conditions to be considered while making the diagnosis
48 Ischemia induces non-isometric vacuolization in tubules
49 Acute arteriolopathy: SMC injury; replacement of damaged myocytes by rounded plasma protein insudates
50 Clinical correlation Acute dysfunction The serum drug level is usually elevated Toxic tubulopathy is reversible Acute arteriolopathy may be irreversible
51 CsA-induced TMA. Fibrin thrombi in glomerular capillary loops Liptak P, Ivanyi B. Nat Clin Pract Nephrol 2: , 2006
52 Differential diagnosis Cannot be differentiated from other forms of TMA by morphology alone Pronounced arterial changes are not typical of CNI-induced TMA Acute humoral rejection (C4d+) Recurrent HUS
53 Clinical correlation Rare Resembles the HUS If the lesions are associated with extensive thrombosis, graft loss develops
54 Chronic toxicity: hyaline arteriolopathy The damaged SMCs are replaced by beaded hyaline deposits that bulge into the adventitia The insudates are positive for IgM and C3
55 Hyaline material (H) is present at sites where media SMCs have dropped out previously. E - swollen endothelial cells, A - apoptotic SMCs.
56 Hyaline arteriolopathy is associated with striped IF/TA
57 Clinical correlation Chronic toxicity occurs several months after Tx; the incidence increases with time A slow, insidious rise in the serum creatinine level The kidney damage is irreversible
58 Differential diagnosis 1) Hyalinosis in ageing, and hypertension Mainly subendothelial and rarely extends into the adventitia Necrosis of the SMCs is not observed Result of the zero Bx is of importance
59 Differential diagnosis 1) Hyalinosis in ageing, and hypertension 2) Diabetic nephropathy 4 changes should be observed simultaneously LM: arteriolar hyalinosis mesangial matrix expansion EM: diffuse thickening of the GBM IF: pseudolinear IgG staining along the glomerular, tubular and Bowman s capsule basement membranes Bhalla et al. Transplantation 75:66, 2003
60 Post-transplantation transplantation glomerulonephritis Exact prevalence of either recurrent or de novo GN is unknown because considerable number of recipients never undergo allograft biopsy
61 Post-transplantation transplantation glomerulonephritis Exact prevalence of either recurrent or de novo GN is unknown because considerable number of recipients never undergo allograft biopsy The diagnosis requires - the routine application of IgG, IgA, IgM, C3, immunostainings - EM to locate the deposits
62 Our series : 618 dysfunctional biopsies were evaluated with LM + IF + EM Transplant glomerulopathy ,3% Post-Tx GN % Systemic disease affecting the glomeruli 8-1.1%
63 Literature analysis White people throughout in Europe develop post-tx GN relatively infrequently indicating that ethnic and geographic differences have an impact on the prevalence Post-Tx GN is the third most important cause of allograft loss at 10 ys after Tx Ivanyi B. Nature Clin Pract Nephrol 4:446, 2008
64 Literature analysis Membranous NP is the most common de novo disease; FSGS, IgAN, and MPGN recur frequently Recurrent or de novo GN often coexists with acute and/or chronic rejection and/or chronic CNI-toxicity, and contribute together to allograft loss Ivanyi B. Nature Clin Pract Nephrol 4:446, 2008
65 Predictors of post-transplantation transplantation GN Male gender, non-white ethnicity, younger age, and biopsy-proven GN in the native kidney Chailimpamontree et al. JASN 20:843, 2009
66 Polyomavirus nephropathy The BK polyomavirus exhibits tropism for the renal tubular epithelium, where it establishes latent infection Vigorous immunosuppression can lead to reactivation of the infection and the development of PVN The definitive diagnosis requires 2 biopsy scores including medulla Drachenberg et al. Hum Pathol 36:1245, 2005
67 Viral replication results in cytopathic changes (nuclear enlargement, inclusion body, tubular cell injury)
68 Marked replication lysis of tubular cells, denudation of TBMs and interstitial inflammation
69 Dg.: immunostaining with SV40 large T-cell antigen
70 EM: virions are 40 nm in diameter, and are arranged in a paracrystalloid structure
71 Differential diagnosis Other viral infections (adenovirus: nm; CMV: nm) Acute TMR (lack of nuclear inclusion bodies, intense tubular HLA-DR expression) Chronic rejection (lack of nuclear inclusion bodies, negative confirmatory tests) Liptak et al. Nature Clin Pract Nephrol 2:631, 2006
72 Histologic patterns and clinical stages of PVN Pattern A Viral replication No tubular cell lysis No denudation of TBMs Early stage No dysfunction Urinary decoy cells Favorable prognosis Hirsch et al. Transplantation 79:1277, 2005
73 Histologic patterns and clinical stages of PVN Pattern A Viral replication No tubular cell lysis No denudation of TBMs Pattern B Viral replication Marked tubular cell lysis Denudation of TBMs Early stage No dysfunction Urinary decoy cells Favorable prognosis Fully developed stage A gradually decreasing renal function Graft loss can exceed 50% Hirsch et al. Transplantation 79:1277, 2005
74 Histologic patterns and clinical stages of PVN Pattern A Viral replication No tubular cell lysis No denudation of TBMs Pattern B Viral replication Marked tubular cell lysis Denudation of TBMs Pattern C Viral replication IF/TA =ci3 and ct3 Early stage No dysfunction Urinary decoy cells Favorable prognosis Fully developed stage A gradually decreasing renal function Graft loss can exceed 50% Late/sclerosing stage A severe dysfunction Graft loss is likely Hirsch et al. Transplantation 79:1277, 2005
75 Summary The application of light microscopic stainings on serial sections an expanded IF panel (C4d,( HLA-DR, IgG, IgA, IgM, C3 tissue sampling for optional EM comparison with a time-zero biopsy DR, IgG, IgA, IgM, C3) enables the pathologist to achieve etiologic diagnoses
76 Biopsy features of acute T-cell-mediated rejection include a) interstitial inflammation (predominance of CD8 lymphocytes) b) tubulitis c) + lymphocytic arteritis
77 The current diagnostic criteria of chronic antibodymediated rejection include a)serologic demonstration of circulating DSAs b) complement 4d-positivity in peritubular capillaries c) morphologic evidence of chronic tissue injury, such as interstitial fibrosis/tubular atrophy and/or arterial intimal fibrosis and/or double contoured glomerular capillary loops and/or peritubular capillary basement membrane lamination
78 Clinical correlation of chronic rejection a) Major cause of graft loss after 1 years b) Insidious, progressive decline in the GFR c) Frequently accompanied by proteinuria and hypertension
79 The most frequent causes of kidney allograft loss at 10 years are a) death with a functioning graft b) chronic antibody-mediated rejection c) chronic calcineurin inhibitor toxicity d) post-transplantation glomerulonephritis
80 Features of chronic calcineurin inhibitor toxicity include a) striped fibrosis and tubular atrophy b) peripheral nodular hyaline deposits in arterioles (hyaline arteriolopathy)
Pathology of Kidney Allograft Dysfunction. B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary
Pathology of Kidney Allograft Dysfunction B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary The renal biopsy is a powerful tool in the diagnostic evaluation of allograft dysfunction
More informationBiopsy Features of Kidney Allograft Rejection Banff B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary
Biopsy Features of Kidney Allograft Rejection Banff 2017 B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary Treatment of allograft dysfunction should rely on the biopsy findings
More informationInterpretation of Renal Transplant Biopsy. Arthur H. Cohen Wake Forest University School of Medicine Winston-Salem, North Carolina USA
Interpretation of Renal Transplant Biopsy Arthur H. Cohen Wake Forest University School of Medicine Winston-Salem, North Carolina USA Renal Transplant Biopsies Tissue Processing Ideal world process as
More informationPrimer: histopathology of calcineurin-inhibitor toxicity in renal allografts
Primer: histopathology of calcineurin-inhibitor toxicity in renal allografts Peter Liptak and Bela Ivanyi* SUMMARY Calcineurin inhibitors (ciclosporin and tacrolimus) can cause acute and chronic nephrotoxicity.
More informationManagement of Rejection
Management of Rejection I have no disclosures Disclosures (relevant or otherwise) Deborah B Adey, MD Professor of Medicine University of California, San Francisco Kidney and Pancreas Transplant Center
More informationStatement of Disclosure
Statement of Disclosure Mark Haas serves as a paid consultant on pathology adjudication committees for two industry-sponsored clinical trials: Shire ViroPharma Treatment of Acute ABMR AstraZeneca Treatment
More informationThe Banff Classification for Diagnosis of Renal Allograft Rejection: Updates from the 2017 Banff Conference
The Banff Classification for Diagnosis of Renal Allograft Rejection: Updates from the 2017 Banff Conference Mark Haas Cedars-Sinai Medical Center Los Angeles, California, USA Statement of Disclosure Mark
More informationDr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust
Dr Ian Roberts Oxford Oxford Pathology Course 2010 for FRCPath Plan of attack: Diagnostic approach to the renal biopsy Differential diagnosis of the clinical syndromes of renal disease Microscopy Step
More informationRenal Pathology- Transplantation. Eva Honsova Institute for Clinical and Experimental Medicine Prague, Czech Republic
Renal Pathology- Transplantation Eva Honsova Institute for Clinical and Experimental Medicine Prague, Czech Republic eva.honsova@ikem.cz Kidney has a limited number of tissue reactions by which the kidney
More informationKidney Summary. Mark Haas Cedars-Sinai Medical Center Los Angeles, California, USA
Kidney Summary Mark Haas Cedars-Sinai Medical Center Los Angeles, California, USA Key Issues to Address re: the Classification 1. Incorporation of i-ifta + tubulitis into the TCMR classification - Defining
More informationReview of Rituximab and renal transplantation. Dr.E Nemati. Professor of Nephrology
Review of Rituximab and renal transplantation Dr.E Nemati Professor of Nephrology Introductio n Rituximab is a chimeric anti-cd20 monoclonal antibody. The CD20 antigen is a transmembrane nonglycosylated
More informationRENAL EVENING SPECIALTY CONFERENCE
RENAL EVENING SPECIALTY CONFERENCE Harsharan K. Singh, MD The University of North Carolina at Chapel Hill Disclosure of Relevant Financial Relationships No conflicts of interest to disclose. CLINICAL HISTORY
More informationCase Presentation Turki Al-Hussain, MD
Case Presentation Turki Al-Hussain, MD Director, Renal Pathology Chapter Saudi Society of Nephrology & Transplantation Consultant Nephropathologist & Urological Pathologist Department of Pathology & Laboratory
More informationMonoclonal Gammopathies and the Kidney. Tibor Nádasdy, MD The Ohio State University, Columbus, OH
Monoclonal Gammopathies and the Kidney Tibor Nádasdy, MD The Ohio State University, Columbus, OH Monoclonal gammopathy of renal significance (MGRS) Biopsies at OSU (n=475) between 2007 and 2016 AL or AH
More informationHLA and Non-HLA Antibodies in Transplantation and their Management
HLA and Non-HLA Antibodies in Transplantation and their Management Luca Dello Strologo October 29 th, 2016 Hystory I 1960 donor specific antibodies (DSA): first suggestion for a possible role in deteriorating
More informationA clinical syndrome, composed mainly of:
Nephritic syndrome We will discuss: 1)Nephritic syndrome: -Acute postinfectious (poststreptococcal) GN -IgA nephropathy -Hereditary nephritis 2)Rapidly progressive GN (RPGN) A clinical syndrome, composed
More informationSurgical Pathology Report
Louisiana State University Health Sciences Center Department of Pathology Shreveport, Louisiana Accession #: Collected: Received: Reported: 6/1/2012 09:18 6/2/2012 09:02 6/2/2012 Patient Name: Med. Rec.
More informationEvolution of the approaches toward grading and classifying chronic changes in the renal allograft: Banff classification updates III
EDITORIAL Advance Access publication 24 February 2014 Evolution of the approaches toward grading and classifying chronic changes in the renal allograft: Banff classification updates III Histopathology
More informationHistopathology: Glomerulonephritis and other renal pathology
Histopathology: Glomerulonephritis and other renal pathology These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you
More informationOrdering Physician. Collected REVISED REPORT. Performed. IgG IF, Renal MCR. Lambda IF, Renal MCR. C1q IF, Renal. MCR Albumin IF, Renal MCR
RenalPath Level IV Wet Ts IgA I Renal IgM I Renal Kappa I Renal Renal Bx Electron Microscopy IgG I Renal Lambda I Renal C1q I Renal C3 I Renal Albumin I Renal ibrinogen I Renal Mayo Clinic Dept. of Lab
More informationPathological back-ground of renal transplant pathology and important mile-stones of the Banff classification
Banff 1 Banff Pathological back-ground of renal transplant pathology and important mile-stones of the Banff classification Department of Nephrology, Japanese Red Cross Nagoya Daini Hospital Morozumi Kunio,
More informationCHAPTER 2. Primary Glomerulonephritis
2nd Report of the PRIMARY GLOMERULONEPHRITIS CHAPTER 2 Primary Glomerulonephritis Sunita Bavanandan Lee Han Wei Lim Soo Kun 21 PRIMARY GLOMERULONEPHRITIS 2nd Report of the 2.1 Introduction This chapter
More informationRecognition and Treatment of Chronic Allograft Dysfunction
Recognition and Treatment of Chronic Allograft Dysfunction Alexander Wiseman, M.D. Associate Professor, Division of Renal Diseases and Hypertension Medical Director, Kidney and Pancreas Transplant Programs
More informationHistopathological evaluation of renal allograft biopsies in Nepal: interpretation and significance
Nepal Medical Association Building Exhibition Road, Kathmandu Journal of Pathology of Nepal (2012) Vol. 2, 172-179 Association of Clinical Pathologist of Nepal-2010 Journal of PATHOLOGY of Nepal www.acpnepal.com
More informationHistopathological findings in transplanted kidneys
Katsuma et al. Renal Replacement Therapy (2017) 3:6 DOI 10.1186/s41100-016-0089-0 REVIEW Histopathological findings in transplanted kidneys Ai Katsuma, Takafumi Yamakawa, Yasuyuki Nakada, Izumi Yamamoto
More informationIndex. electron microscopy, 81 immunofluorescence microscopy, 80 light microscopy, 80 Amyloidosis clinical setting, 185 etiology/pathogenesis,
A Acute antibody-mediated rejection (Acute AMR) clinical features, 203 clinicopathologic correlations, 206 pathogenesis, 205 206 204 205 light microscopy, 203 204 Acute cellular rejection (ACR) clinical
More informationClassification of Glomerular Diseases and Defining Individual Glomerular Lesions: Developing International Consensus
Classification of Glomerular Diseases and Defining Individual Glomerular Lesions: Developing International Consensus Mark Haas MD, PhD Department of Pathology & Laboratory Medicine Cedars-Sinai Medical
More informationRECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT. J. H. Helderman,MD,FACP,FAST
RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT J. H. Helderman,MD,FACP,FAST Vanderbilt University Medical Center Professor of Medicine, Pathology and Immunology Medical Director, Vanderbilt Transplant
More informationDr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust
Dr Ian Roberts Oxford Oxford Pathology Course 2010 for FRCPath Present the basic diagnostic features of the commonest conditions causing proteinuria & haematuria Highlight diagnostic pitfalls Nephrotic
More informationGlomerular pathology in systemic disease
Glomerular pathology in systemic disease Lecture outline Lupus nephritis Diabetic nephropathy Glomerulonephritis Associated with Bacterial Endocarditis and Other Systemic Infections Henoch-Schonlein Purpura
More informationGlomerular diseases mostly presenting with Nephritic syndrome
Glomerular diseases mostly presenting with Nephritic syndrome 1 The Nephritic Syndrome Pathogenesis: proliferation of the cells in glomeruli & leukocytic infiltrate Injured capillary walls escape of RBCs
More informationHistopathology: Hypertension and diabetes in the kidney These presentations are to help you identify basic histopathological features.
Histopathology: Hypertension and diabetes in the kidney These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need
More informationYear 2004 Paper one: Questions supplied by Megan
QUESTION 53 Endothelial cell pathology on renal biopsy is most characteristic of which one of the following diagnoses? A. Pre-eclampsia B. Haemolytic uraemic syndrome C. Lupus nephritis D. Immunoglobulin
More informationThe new Banff vision of the role of HLA antibodies in organ transplantation: Improving diagnostic system and design of clinical trials
The new Banff vision of the role of HLA antibodies in organ transplantation: Improving diagnostic system and design of clinical trials Carmen Lefaucheur 1 2 Banff 2015: Integration of HLA-Ab for improving
More informationImmunopathology of T cell mediated rejection
Immunopathology of T cell mediated rejection Ibrahim Batal MD Columbia University College of Physicians & Surgeons New York, NY, USA Overview Pathophysiology and grading of TCMR TCMR is still a significant
More informationInterstitial Inflammation
Interstitial Inflammation Currently considered to be T cell-mediated process Plasma cell rich acute rejection often associated with AMR Preliminary data suggests that interstitial follicular helper T cells
More informationGlomerular pathology-2 Nephritic syndrome. Dr. Nisreen Abu Shahin
Glomerular pathology-2 Nephritic syndrome Dr. Nisreen Abu Shahin 1 The Nephritic Syndrome Pathogenesis: inflammation proliferation of the cells in glomeruli & leukocytic infiltrate Injured capillary walls
More informationDr Ian Roberts Oxford
Dr Ian Roberts Oxford Oxford Pathology Course 2010 for FRCPath Present the basic diagnostic features of the commonest conditions causing renal failure Highlight diagnostic pitfalls. Crescentic GN: renal
More informationKidneytransplant pathologyrelatedto immunosuppressiveagents
Kidneytransplant pathologyrelatedto immunosuppressiveagents Helmut Hopfer Pathologie Women, 53 years old. 16 months after kidney transplantation for diabetic nephropathy. Metabolicsyndromeandcoronaryheartdisease.
More informationRenal Pathology 1: Glomerulus. With many thanks to Elizabeth Angus PhD for EM photographs
Renal Pathology 1: Glomerulus With many thanks to Elizabeth Angus PhD for EM photographs Anatomy of the Kidney http://www.yalemedicalgroup.org/stw/page.asp?pageid=stw028980 The Nephron http://www.beltina.org/health-dictionary/nephron-function-kidney-definition.html
More informationCHAPTER 2 PRIMARY GLOMERULONEPHRITIS
CHAPTER 2 Sunita Bavanandan Lim Soo Kun 19 5th Report of the 2.1: Introduction This chapter covers the main primary glomerulonephritis that were reported to the MRRB from the years 2005-2012. Minimal change
More informationRejection or Not? Interhospital Renal Meeting 10 Oct Desmond Yap & Sydney Tang Queen Mary Hospital
Rejection or Not? Interhospital Renal Meeting 10 Oct 2007 Desmond Yap & Sydney Tang Queen Mary Hospital Case Presentation F/61 End stage renal failure due to unknown cause Received HD in private hospital
More informationRENAL HISTOPATHOLOGY
RENAL HISTOPATHOLOGY Peter McCue, M.D. Department of Pathology, Anatomy & Cell Biology Sidney Kimmel Medical College There are no conflicts of interest. 1 Goals and Objectives! Goals Provide introduction
More informationAcute renal failure (ARF) in the transplanted kidney represents a
Acute Renal Failure in the Transplanted Kidney Kim Solez Lorraine C. Racusen Acute renal failure (ARF) in the transplanted kidney represents a high-stakes area of nephrology and of transplantation practice.
More informationRECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT
RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT HISTOPATHOLOGIC DISORDERS AFFECTING THE ALLOGRAFT OTHER THAN REJECTION RECURRENT DISEASE DE NOVO DISEASE TRANSPLANT GLOMERULOPATHY Glomerular Non-glomerular
More informationThe transcriptome of the renal transplant biopsy: the lessons. Philip F Halloran
The transcriptome of the renal transplant biopsy: the lessons Philip F Halloran Alberta Transplant Applied Genomics Centre April 27 th 2009 Congratulations on your 50 th anniversary ATAGC Learning objectives:
More informationPathology of Complement Mediated Renal Disease
Pathology of Complement Mediated Renal Disease Mariam Priya Alexander, MD Associate Professor of Pathology GN Symposium Hong Kong Society of Nephrology July 8 th, 2017 2017 MFMER slide-1 The complement
More informationSpecial thanks to our clinical collaborators Special thanks to our patients. Administration. Andre Baretto
Antibody-mediated rejection: a prototype for antibody-mediated diseases Phil Halloran Alberta Transplant Applied Genomics Centre Edmonton, Canada Disclosures PFH has shares in TSI a university spinoff
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Lefaucheur C, Loupy A, Vernerey D, et al. Antibody-mediated
More informationThe Banff Conferences on renal allograft pathology the latest 2013 report
615245PSH0010.1177/2010105815615245Proceedings of Singapore HealthcareLoh research-article2015 Review Article PROCEEDINGS OF SINGAPORE HEALTHCARE The Banff Conferences on renal allograft pathology the
More informationGlomerular diseases with organized deposits
Glomerular diseases with organized deposits Banu Sis, MD, FRCPC University of Alberta, Edmonton, AB, Canada Ulusal Patoloji Kongresi, Manavgat, Antalya 8/11/2012 What is an organized deposit? A number
More informationChronic Active TCMR: clinical implications
Chronic Active TCMR: i, iatr, i-ifta, and the clinical implications Roslyn B. Mannon, M.D. Professor of Medicine, Division of Nephrology Professor of Surgery, Division of Transplantation Director of Research,
More informationInteresting case seminar: Native kidneys Case Report:
Interesting case seminar: Native kidneys Case Report: Proximal tubulopathy and light chain deposition disease presented as severe pulmonary hypertension with right-sided cardiac dysfunction and nephrotic
More informationC1q nephropathy the Diverse Disease
C1q nephropathy the Diverse Disease Danica Galešić Ljubanović School of Medicine, University of Zagreb Dubrava University Hospital Zagreb, Croatia Definition Dominant or codominant ( 2+), mesangial staining
More informationGlomerular Pathology- 1 Nephrotic Syndrome. Dr. Nisreen Abu Shahin
Glomerular Pathology- 1 Nephrotic Syndrome Dr. Nisreen Abu Shahin The Nephrotic Syndrome a clinical complex resulting from glomerular disease & includes the following: (1) massive proteinuria (3.5 gm /day
More informationFamilial DDD associated with a gain-of-function mutation in complement C3.
Familial DDD associated with a gain-of-function mutation in complement C3. Santiago Rodríguez de Córdoba, Centro de investigaciones Biológicas, Madrid Valdés Cañedo F. and Vázquez- Martul E., Complejo
More informationCase 3. ACCME/Disclosure. Laboratory results. Clinical history 4/13/2016
Case 3 Lynn D. Cornell, M.D. Mayo Clinic, Rochester, MN Cornell.Lynn@mayo.edu USCAP Renal Case Conference March 13, 2016 ACCME/Disclosure Dr. Cornell has nothing to disclose Clinical history 57-year-old
More informationOverview of glomerular diseases
Overview of glomerular diseases *Endothelial cells are fenestrated each fenestra: 70-100nm in diameter Contractile, capable of proliferation, makes ECM & releases mediators *Glomerular basement membrane
More informationFIBRILLARY GLOMERULONEPHRITIS DIAGNOSTIC CRITERIA, PITFALLS, AND DIFFERENTIAL DIAGNOSIS
FIBRILLARY GLOMERULONEPHRITIS DIAGNOSTIC CRITERIA, PITFALLS, AND DIFFERENTIAL DIAGNOSIS Guillermo A. Herrera MD Louisiana State University, Shreveport Fibrils in bundles 10-20 nm d Diabetic fibrillosis
More informationCase Report A Clinical and Pathological Variant of Acute Transplant Glomerulopathy
Case Report A Clinical and Pathological Variant of Acute Transplant Glomerulopathy Miklos Z. Molnar, 1 G. V. Ramesh Prasad, 2 Darren A. Yuen, 2,3 Serge Jothy, 4 and Jeffrey S. Zaltzman 2,5 1 Division of
More informationCase # 2 3/27/2017. Disclosure of Relevant Financial Relationships. Clinical history. Clinical history. Laboratory findings
Case # 2 Christopher Larsen, MD Arkana Laboratories Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content
More informationUpdate on Transplant Glomerulopathy
Update on Transplant Glomerulopathy Miklos Z Molnar, MD, PhD, FEBTM, FERA, FASN Associate Professor of Medicine Division of Nephrology, Department of Medicine University of Tennessee Health Science Center
More informationC3 Glomerulopathy. Jun-Ki Park
C3 Glomerulopathy Jun-Ki Park 03.08.11 For the last 30 years classification MPGN is based on glomerular findings by light microscopy with further specification on EM and staining for Ig and complement
More informationThe Histology of Kidney Transplant Failure: A Long-Term Follow-Up Study
CLINICAL AND TRANSLATIONAL RESEARCH The Histology of Kidney Transplant Failure: A Long-Term Follow-Up Study Maarten Naesens, 1,2,6 Dirk R.J. Kuypers, 1,2 Katrien De Vusser, 1,2 Pieter Evenepoel, 1,2 Kathleen
More informationNo evidence of C4d association with AMR However, C3d and AMR correlated well
C4d positivity Poor prognostic factor Reversal to C4d negativity did not change prognosis, with current therapy Prognostic factor for CAV Variable time line for CAV/death No correlation with cellular rejection
More informationPeritubular capillaries C4d deposits in renal allograft biopsies and anti HLA I/II alloantibodies screening Incidence and clinical importance
ORIGINAL ARTICLE Port J Nephrol Hypert 2008; 22(1): 37-42 Peritubular capillaries C4d deposits in renal allograft biopsies and anti HLA I/II alloantibodies screening Incidence and clinical importance Helena
More informationCKD in Other Organ Transplants
CKD in Other Organ Transplants Alexander Wiseman, M.D. Associate Professor, Division of Renal Diseases and Hypertension Medical Director, Kidney and Pancreas Transplant Programs University of Colorado
More informationLight and electron microscopical studies of focal glomerular sclerosis
J. clin. Path., 1971, 24, 846-850 Light and electron microscopical studies of focal glomerular sclerosis A. H. NAGI, F. ALEXANDER, AND R. LANNIGAN From the Department of Pathology, Queen's University of
More informationResearch Article The Diagnostic Value of Transcription Factors T-bet/GATA3 Ratio in Predicting Antibody-Mediated Rejection
Clinical and Developmental Immunology Volume 2013, Article ID 460316, 6 pages http://dx.doi.org/10.1155/2013/460316 Research Article The Diagnostic Value of Transcription Factors T-bet/GATA3 Ratio in Predicting
More informationMembranoproliferative Glomerulonephritis
Membranoproliferative Glomerulonephritis MPGN is characterizedby alterations in the GBM and mesangium and by proliferation of glomerular cells. 5% to 10% of cases of 1ry nephrotic syndrome in children
More informationRecurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab
TRANSPLANTATION Recurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab Khadijeh Makhdoomi, 1,2 Saeed Abkhiz, 1,2 Farahnaz Noroozinia, 1,3
More informationDiagnosis and Management of Acute and Chronic Humoral Rejection. Lars Pape
Diagnosis and Management of Acute and Chronic Humoral Rejection Lars Pape Immunosuppression Acute rejection Chronic rejection Side effects Infections Nephrotoxicity Adult population Nearly all late rejection-related
More informationProgressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes
http://www.kidney-international.org & 2011 International Society of Nephrology see commentary on page 1254 Progressive histological damage in renal allografts is associated with expression of innate and
More informationACCME/Disclosure. Case #1. Case History. Dr. Bracamonte has nothing to disclose
Case #1 ACCME/Disclosure Dr. Erika Bracamonte Associate Professor of Pathology University of Arizona, College of Medicine Banner University Medical Center, Tucson Dr. Bracamonte has nothing to disclose
More informationMayo Clinic/ RPS Consensus Report on Classification, Diagnosis, and Reporting of Glomerulonephritis
Mayo Clinic/ RPS Consensus Report on Classification, Diagnosis, and Reporting of Glomerulonephritis Sanjeev Sethi, MD, PhD Department of Laboratory Medicine and Pathology Disclosure Relevant Financial
More informationJames E. Cooper, M.D. Assistant Professor, University of Colorado at Denver Division of Renal Disease and Hypertension, Kidney and PancreasTransplant
James E. Cooper, M.D. Assistant Professor, University of Colorado at Denver Division of Renal Disease and Hypertension, Kidney and PancreasTransplant Program Has no real or apparent conflicts of interest
More informationThe Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology The Harvard community has made this article openly available. Please
More informationJournal of Nephropathology
www.nephropathol.com DOI: 10.15171/jnp.2018.24 J Nephropathol. 2018;7(3):101-105 Journal of Nephropathology Relationship of CD147 kidney expression with various pathologic lesions, biochemical and demographic
More informationCase Presentation Turki Al-Hussain, MD
Case Presentation Turki Al-Hussain, MD Director, Renal Pathology Chapter Saudi Society of Nephrology & Transplantation Consultant Nephropathologist & Urological Pathologist Department of Pathology & Laboratory
More informationUpdate on Transplant Glomerulopathy
Update on Transplant Glomerulopathy Miklos Z Molnar, MD, PhD, FEBTM, FERA, FASN Associate Professor of Medicine Methodist University Hospital, Transplant Institute Division of Transplantation, Department
More informationBK virus infection in renal transplant recipients: single centre experience. Dr Wong Lok Yan Ivy
BK virus infection in renal transplant recipients: single centre experience Dr Wong Lok Yan Ivy Background BK virus nephropathy (BKVN) has emerged as an important cause of renal graft dysfunction in recent
More informationSome renal vascular disorders
Some renal vascular disorders Introduction Nearly all diseases of the kidney involve the renal blood vessels secondarily We will discuss: -Hypertension (arterionephrosclerosis in benign HTN & hyperplastic
More informationPost-Transplant Monitoring for the Development of Anti-Donor HLA Antibodies
Post-Transplant Monitoring for the Development of Anti-Donor HLA Antibodies Lorita M Rebellato, Ph.D., D (ABHI) Associate Professor Department of Pathology The Brody School of Medicine at ECU Scientific
More informationSCORING OF i-ifta: POTENTIAL RULES & ROLE IN CHRONIC TCMR
SCORING OF i-ifta: POTENTIAL RULES & ROLE IN CHRONIC TCMR Parmjeet Randhawa, MD Professor of Pathology The Thomas E Starzl Transplantation Institute University of Pittsburgh . I HAVE NO CONFLICTS OR FINANCIAL
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationCrescentic Glomerulonephritis (RPGN)
Crescentic Glomerulonephritis (RPGN) Background Rapidly progressive glomerulonephritis (RPGN) is defined as any glomerular disease characterized by extensive crescents (usually >50%) as the principal histologic
More informationClassification of Glomerular Diseases and Defining Individual Glomerular Lesions: Developing International Consensus
Classification of Glomerular Diseases and Defining Individual Glomerular Lesions: Developing International Consensus Mark Haas MD, PhD Department of Pathology & Laboratory Medicine Cedars-Sinai Medical
More informationNephritic vs. Nephrotic Syndrome
Page 1 of 18 Nephritic vs. Nephrotic Syndrome Terminology: Glomerulus: A network of blood capillaries contained within the cuplike end (Bowman s capsule) of a nephron. Glomerular filtration rate: The rate
More informationHRZZ project: Genotype-Phenotype correlation in Alport's syndrome and Thin Glomerular Basement Membrane Nephropathy. Patohistological Aspects
HRZZ project: Genotype-Phenotype correlation in Alport's syndrome and Thin Glomerular Basement Membrane Nephropathy Patohistological Aspects Petar Šenjug, MD 1 Professor Danica Galešić Ljubanović, MD,
More informationDeján Dobi, MD. PhD Thesis
Clinicopathologic Relevance of Vascular Changes Associated with Transplant Glomerulopathy Secondary to Chronic Antibody-mediated Rejection in the Renal Allograft Deján Dobi, MD PhD Thesis Szeged, 2018
More informationClinical pathological correlations in AKI
Clinical pathological correlations in AKI Dr. Rajasekara chakravarthi Director - Nephrology Star Kidney Center, Star Hospitals Renown clinical services India Introduction AKI is common entity Community
More informationNEPHRITIC SYNDROME. By Dr Mai inbiek
NEPHRITIC SYNDROME By Dr Mai inbiek Nephritic Syndrome The nephritic Syndrome is a clinical complex, usually of acute onset. Is caused by inflammatory lesions of glomeruli. Characterized by; 1) Hematuria
More informationMICROSCOPIC HEMATURIA AND DIFFUSE NECROTIZING GLOMERULONEPHRITIS
MICROSCOPIC HEMATURIA AND DIFFUSE NECROTIZING GLOMERULONEPHRITIS Hatim Q. AlMaghrabi, MD, FRCPC Consultant at King Abdulaziz Medical City (NGHA) Jeddah Case Presentation 70 years old female Known hypertensive
More informationSegmental glomerulonephritis
M. S. DUNNILL AND P. R. MILLARD From the Gibson Laboratories, Radcliffe Infirmary, Oxford J. clin. Path., 1975, 28, 167-175 SYNOPSIS The renal biopsy findings in 40 patients with segmental glomerulonephritis
More informationSince the first Banff meeting in 1991, the diagnosis and
CLINICAL AND TRANSLATIONAL RESEARCH Acute Cellular Rejection: Impact of Donor-Specific Antibodies and C4d Michelle Willicombe, 1,5 Candice Roufosse, 2 Paul Brookes, 3 Adam G. McLean 1, Jack Galliford,
More informationDr. Rai Muhammad Asghar Head of Paediatric Department BBH Rawalpindi
Dr. Rai Muhammad Asghar Head of Paediatric Department BBH Rawalpindi Acute Post streptococcal Glomerulonephritis Sudden onset of Gross hematuria Edema Hypertension Renal insufficiency Cause of AGN Post
More informationSecondary IgA Nephropathy & HSP
Secondary IgA Nephropathy & HSP Anjali Gupta, MD 1/11/11 AKI sec to Hematuria? 65 cases of ARF after an episode of macroscopic hematuria have been reported in the literature in patients with GN. The main
More informationThe Value of Electron Microscopy in the Diagnosis of Chronic Renal Allograft Rejection
The Value of Electron Microscopy in the Diagnosis of Chronic Renal Allograft Rejection B. Ivanyi, M.D., E. Kemeny, M.D., E. Szederkenyi, M.D., F. Marofka, M.D., P. Szenohradszky, M.D. Departments of Pathology
More informationAntibody Mediated Rejection (AMR) in Heart Transplantation Session
Page 1 Antibody Mediated Rejection (AMR) in Heart Transplantation Session Dear Colleagues: The Heart session at Banff this year will be solely focused on AMR and besides the fact that many of us attending
More informationElevated Serum Creatinine, a simplified approach
Elevated Serum Creatinine, a simplified approach Primary Care Update Creighton University School of Medicine. April 27 th, 2018 Disclosure Slide I have no disclosures and have no conflicts with this presentation.
More information